Coronary atherosclerosis: Extending to the microcirculation?

European Heart Journal

Volumn 31, Issue 8, 2010, Pages 905-907

  Panza, Julio A ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENOSINE; LACTIC ACID; NITRATE;

ANGIOCARDIOGRAPHY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY FLOW RESERVE; CORONARY VASCULAR RESISTANCE; DIABETES MELLITUS; ELECTROSTIMULATION; ENDOCARDIUM; ENDOTHELIAL DYSFUNCTION; EPICARDIUM; EXERCISE; FRAMINGHAM RISK SCORE; HEART MUSCLE; HEART MUSCLE FIBER MEMBRANE CONDUCTANCE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MICROCIRCULATION; MICROVASCULATURE; NOCICEPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RESISTANCE BLOOD VESSEL; REVIEW; RISK FACTOR; SMOKING; ST SEGMENT DEPRESSION; SYNDROME X; THORAX PAIN; VASCULAR BIOLOGY; VASODILATATION; CORONARY BLOOD VESSEL; NOTE; PHYSIOLOGY; VASCULAR RESISTANCE;

CORONARY ARTERY DISEASE; CORONARY VESSELS; HUMANS; MICROCIRCULATION; VASCULAR RESISTANCE;

EID: 79955667190     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq044     Document Type: Review

References (18)

1. Amezcua JL, Palmer RMJ, de Souza BM, Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol 1989;97:1119-1124. (Pubitemid 20051925)
2. Quyyumi AA, Dakak N, Andrews NP, Hussain S, Arora S, Gilligan DM, Panza JA, Cannon RO. Nitric oxide in the human coronary circulation. Impact of risk factors for atherosclerosis. J Clin Invest 1995;95:1747-1755.
3. Kuo L, Chilian WM, Davis MJ. Coronary arteriolar myogenic response is independent of endothelium. Circ Res 1990;66:860-866. (Pubitemid 20086923)
4. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356: 830-840.
5. Kemp HG. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 1973;32:375-376.
6. Cannon RO. Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms. J Am Coll Cardiol 2009;54:877-885.
7. Panza JA, Laurienzo JM, Curiel RV, Unger EF, Quyyumi AA, Dilsizian V, Cannon RO. Investigation of the mechanism of chest pain in patients with angio-graphically normal coronary arteries using transesophageal dobutamine stress echocardiography. J Am Coll Cardiol 1997;29:293-301. (Pubitemid 27059957)
8. Cannon RO, Quyyumi AA, Schenke WH, Fananapazir L, Tucker EE, Gaughan AM, Gracely RH, Cattau EL Jr, Epstein SE. Abnormal cardiac pain sensitivity in patients with chest pain and normal coronary arteries. J Am Coll Cardiol 1990;16: 1359-1366.
9. Rosen SD, Paulesu E, Wise RJ, Camici PG. Central neural contribution to the perception of chest pain in cardiac syndrome X. Heart 2002;87: 513-519. (Pubitemid 34547972)
10. Cannon RO, Quyyumi AA, Mincemoyer R, Stine AM, Gracely RH, Smith WB, Geraci MF, Black BC, Uhde TW, Waclawiw MA, Maher K, Benjamin SB. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994;330:1411-1417. (Pubitemid 24139233)
11. Maseri A, Crea F, Kaski JC, Crake T. Mechanism of angina pectoris in syndrome X. J Am Coll Cardiol 1991;17:499-506.
12. Panza JA. Myocardial ischemia and the pains of the heart. N Engl J Med 2002;346: 934-1935.
13. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endo-thelium. N Engl J Med 1990;323:27-36.
14. Drexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 1997; 39:287-324. (Pubitemid 27120399)
15. Barac A, Campia U, Panza JA. Methods for evaluating endothelial function in humans. Hypertension 2007;49:748-760. (Pubitemid 351664221)
16. Rubinshtein R, Yang EH, Rihal CS, Prasad A, Lennon RJ, Best PJ, Lerman LO, Lerman A. Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham risk score. Eur Heart J 2010;31:936-942. First published on 6 November 2009. doi:10.1093/eurheartj/ehp459.
17. Halcox JPJ, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KRA, Quyyumi AA. Prognostic value of coronary vascular endothelial function. Circulation 2002;106;653-658. (Pubitemid 34851922)
18. Von Mering GO, Arant CB, Wessel TR, McGorray SP, Bairey Merz CN, Sharaf BL, Smith KM, Olson MB, Johnson BD, Sopko G, Handberg E, Pepine CJ, Kerensky RA. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004;109:722-725. (Pubitemid 38222890)